Clinical Trials
42 trialsSTBETA
University Hospital, Bordeaux
EpiCom
Jazz Pharmaceuticals
RAINBOW
University of California, Los Angeles
Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy
Longboard Pharmaceuticals
Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs.
GRIN Therapeutics, Inc.
Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy
Marinus Pharmaceuticals
Basimglurant (NOE-101) in Children, Adolescents, and Young Adults With TSC
Noema Pharma AG
Clinical Study of NPC-12Y Gel in Patients With Skin Lesions Associated With TSC
Nobelpharma
PACIFIC
Longboard Pharmaceuticals
KidneYou - Innovative Digital Therapy
Advice Pharma Group srl
TRAIN
University of California, Los Angeles
Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex
University of Alabama at Birmingham
STOP2
Children's Hospital Medical Center, Cincinnati
Efficacy and Safety of CircadinĀ® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities
Neurim Pharmaceuticals Ltd.
Dose-Ranging Efficacy and Safety Study of Topical Rapamycin Cream for Facial Angiofibroma Associated With Tuberous Sclerosis Complex
Dermatology Specialties Limited Partnership
TSC
Marinus Pharmaceuticals
A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)
Jazz Pharmaceuticals
An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)
Jazz Pharmaceuticals
RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS
Dana-Farber Cancer Institute
Safety and Efficacy of Everolimus (AfinitorĀ®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.
Novartis
A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD
NYU Langone Health
RAPT
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
ELEKTRA
Takeda
Treatment
The University of Texas Health Science Center, Houston
Everolimus for Cancer With TSC1 or TSC2 Mutation
Dana-Farber Cancer Institute
SOS
University of Pennsylvania
Long-term Trial of Topical Sirolimus to Angiofibroma in Patient With Tuberous Sclerosis Complex
Nobelpharma
Early Behavioral Intervention to Improve Social Communication Function in Infants With Tuberous Sclerosis Complex
University of California, Los Angeles
TSC
Boston Children's Hospital
Topical Rapamycin and Calcitriol for Angiofibroma of Tuberous Sclerosis
National Taiwan University Hospital
Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC)
Children's Hospital Medical Center, Cincinnati
EXIST-2
Novartis
Phase III Trial of Topical Formulation of Sirolimus to Skin Lesions in Patients With Tuberous Sclerosis Complex (TSC)
Nobelpharma
Tuberous Sclerosis Complex: Facial Angiofibroma Skin Cream
Le Bonheur Children's Hospital
EXIST-1
Novartis
Doxycycline In Lymphangioleiomyomatosis (LAM)
University of Nottingham
Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex
Children's Hospital Medical Center, Cincinnati
Assessment of the Pharmacokinetics of CircadinĀ® in Children With Neurodevelopmental Disorders and Sleep Disturbances
Neurim Pharmaceuticals Ltd.
RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM
Children's Hospital Medical Center, Cincinnati
Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM)
Children's Hospital Medical Center, Cincinnati
Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1)
The University of Texas Health Science Center, Houston
Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM
Children's Hospital Medical Center, Cincinnati